Biodistribution of etoposide via intratumoral chemotherapy with etoposide-loaded implants
Etoposide (VP16) is the traditional antitumor agent which has been widely used in a variety of cancers. However, intravenous administration of VP16 was limited in clinical application because of its low aqueous solubility, poor bioavailability and dose-limiting adverse effects. Local chemotherapy wi...
| Published in: | Drug Delivery |
|---|---|
| Main Authors: | , , , , , , , |
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2020-01-01
|
| Subjects: | |
| Online Access: | http://dx.doi.org/10.1080/10717544.2020.1787558 |
